Protein kinase inhibitors

Details for Australian Patent Application No. 2009330365 (hide)

Owner Eli Lilly and Company

Inventors Coates, David Andrew; De Dios Magana, Alfonso; De Prado Gonzales, Ana; Del Prado Catalina, Miriam Filadelfa; Garcia Paredes, Maria Cristina; Gelbert, Lawrence Mark; Knobeloch, John Monte; Martin De La Nava, Eva Maria; Martin Ortega Finger, Maria Dolores; Martinez Perez, Jose Antonio; Mateo Herranz, Ana Isabel; Perez Martinez, Carlos; Sanchez Martinez, Concepcion

Agent Spruson & Ferguson

Pub. Number AU-B-2009330365

PCT Pub. Number WO2010/075074

Priority 08380343.7 22.12.08 EP; 61/154,954 24.02.09 US

Filing date 15 December 2009

Wipo publication date 1 July 2010

Acceptance publication date 12 July 2012

International Classifications

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

A61K 31/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 Antineoplastic agents

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/075074 Priority application(s): WO2010/075074

12 July 2012 Application Accepted

  Published as AU-B-2009330365

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009330367-Endoscopic scissors instrument

2009330355-Triple reuptake inhibitors and methods of their use